Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.10.0.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenues $ 0 $ 0
Operating expenses:    
Research and development 1,774,454 935,319
In-process research and development 0 14,501,622
General and administrative 1,628,308 1,166,186
Total operating expenses 3,402,762 16,603,127
Loss from operations (3,402,762) (16,603,127)
Other income:    
Interest and other income 103,215 48,255
Loss before income tax benefit (3,299,547) (16,554,872)
Deferred income tax benefit 71,615 0
Net loss (3,227,932) (16,554,872)
Other comprehensive income (loss):    
Foreign currency translation loss (2,396) 0
Comprehensive loss $ (3,230,328) $ (16,554,872)
Net loss per share:    
Basic and diluted $ (0.35) $ (1.89)
Weighted average shares outstanding:    
Basic and diluted 9,291,421 8,782,037